Next Article in Journal
Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals
Next Article in Special Issue
A Correlation Study of DHA Dietary Intake and Plasma, Erythrocyte and Breast Milk DHA Concentrations in Lactating Women from Coastland, Lakeland, and Inland Areas of China
Previous Article in Journal
An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
Previous Article in Special Issue
Australians are not Meeting the Recommended Intakes for Omega-3 Long Chain Polyunsaturated Fatty Acids: Results of an Analysis from the 2011–2012 National Nutrition and Physical Activity Survey
Article Menu

Export Article

Open AccessReview

Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes

Department of Nutrition and Preventive Medicine, Norwich Medical School, BCRE, University of East Anglia (UEA), James Watson Road, Norwich NR4 7UQ, UK
Nutrients 2016, 8(3), 123;
Received: 24 January 2016 / Revised: 15 February 2016 / Accepted: 23 February 2016 / Published: 2 March 2016
(This article belongs to the Special Issue DHA for Optimal Health)
PDF [802 KB, uploaded 2 March 2016]


At a population level, cardioprotective and cognitive actions of the fish oil (FO) derived long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been extensively demonstrated. In addition to dietary intake, which is limited for many individuals, EPA and DHA status is dependent on the efficiency of their biosynthesis from α-linolenic acid. Gender and common gene variants have been identified as influencing the rate-limiting desaturase and elongase enzymes. Response to a particular intake or status is also highly heterogeneous and likely influenced by genetic variants which impact on EPA and DHA metabolism and tissue partitioning, transcription factor activity, or physiological end-point regulation. Here, available literature relating genotype to tissue LC n-3 PUFA status and response to FO intervention is considered. It is concluded that the available evidence is relatively limited, with much of the variability unexplained, though APOE and FADS genotypes are emerging as being important. Although genotype × LC n-3 PUFA interactions have been described for a number of phenotypes, few have been confirmed in independent studies. A more comprehensive understanding of the genetic, physiological and behavioural modulators of EPA and DHA status and response to intervention is needed to allow refinement of current dietary LC n-3 PUFA recommendations and stratification of advice to “vulnerable” and responsive subgroups. View Full-Text
Keywords: eicosapentaenoic acid; EPA; docosahexaenoic acid; DHA; long chain n-3 PUFA; genotype; APOE; FADS eicosapentaenoic acid; EPA; docosahexaenoic acid; DHA; long chain n-3 PUFA; genotype; APOE; FADS

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Printed Edition Available!
A printed edition of this Special Issue is available here.

Share & Cite This Article

MDPI and ACS Style

Minihane, A.M. Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes. Nutrients 2016, 8, 123.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top